Solvonis Therapeutics 

Graft Polymer (UK) Plc specializes in the advancement and refinement of polymer modification technologies, operating primarily within the United Kingdom and across Europe. The company provides an extensive portfolio of specialized materials, including GRAFTABOND, a series of graft/block copolymers that facilitate the integration of various polymers with substances like fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN offers reactive solid super-concentrates, utilized for polyolefin rheology adjustment, e-modulus enhancement, PET/PBT chain extension, and as AOX masterbatches. GRAFTAPOR supplies porous polymer carriers, designed for liquid chemical applications. Additionally, GRAFTAMID delivers high-temperature elastomers, formulated from nanostructured polyolefin-polyamide alloys, serving as advanced hardening modifiers in polyamide compounds or as standalone hot melt adhesives. GRAFTAKIT comprises reactive liquid or solid super-concentrates, delivered via porous polymeric media, essential for reaction extrusion and compound alteration processes. Furthermore, GRAFTALLOY consists of polymer-polymer nano-alloys engineered to significantly improve abrasion and temperature resistance, enhance impact strength, and reduce friction coefficients. GRAFTASYNT features synthetic products, including halogen-free flame retardants. Lastly, GRAFTAMER is an intelligent polymer possessing thermo-reversible crosslinking, self-hardening, self-healing capabilities, and shape memory functionality. The company was founded in 2017 and is based in London, United Kingdom.